Treatment outcomes following continuous miglustat therapy in
Por um escritor misterioso
Last updated 21 março 2025

Background Niemann-Pick disease Type C (NP-C) is a rare, progressive neurodegenerative disorder characterized by progressive neurodegeneration and premature death. We report data at closure of the NPC Registry that describes the natural history, disease course and treatment experience of NP-C patients in a real-world setting. Methods The NPC Registry was a prospective observational cohort study that ran between September 2009 and October 2017. Patients with a confirmed diagnosis of NP-C were enrolled regardless of treatment status. All patients underwent clinical assessments and medical care as determined by their physicians; data were collected through a secure internet-based portal. Results At closure on October 19, 2017, 472 patients from 22 countries were enrolled in the NPC Registry. Mean (standard deviation) age at enrollment was 21.2 (15.0) years, and 51.9% of patients were male. First neurological symptom onset occurred during the early-infantile (< 2 years), late-infantile (2 to < 6 years), juvenile (6 to < 15 years), or adolescent/adult (≥ 15 years) periods in 13.5, 25.6, 31.8, and 29.1% of cases, respectively. The most frequent neurological manifestations prior to enrollment included ataxia (67.9%), vertical supranuclear gaze palsy (67.4%), dysarthria (64.7%), cognitive impairment (62.7%), dysphagia (49.1%), and dystonia (40.2%). During infancy, splenomegaly and hepatomegaly were frequent (n = 199/398 [50%] and n = 147/397 [37.0%], respectively) and persisted in most affected patients. Of the 472 enrolled patients, 241 were continuously treated with miglustat during the NPC Registry observation period, of whom 172 of these 241 patients were treated continuously for ≥12 months. A composite disability score that assesses impairment of ambulation, manipulation, language, and swallowing was highest in the early-infantile population and lowest in the adolescent/adult population. Among the continuous miglustat therapy population, 70.5% of patients had improved or had stable disease (at least 3 of the 4 domains having a decreased or unchanged score between enrollment and last follow-up). The NPC Registry did not identify any new safety signals associated with miglustat therapy. Conclusions The profiles of clinical manifestations in the final NPC Registry dataset agreed with previous clinical descriptions. Miglustat therapy was associated with a stabilization of neurological manifestations in most patients. The safety and tolerability of miglustat therapy was consistent with previous reports.

Frontiers Therapeutic Strategies For Tay-Sachs Disease

EP2796457A1 - Genz 112638 for treating Gaucher or Fabry disease in

Therapeutic advantages of combined gene/cell therapy strategies in

Long term follow-up to evaluate the efficacy of miglustat

Opfolda: Package Insert

Randomized, controlled trial of miglustat in Gaucher's disease

Miglustat in late-onset Tay-Sachs disease: a 12-month, randomized

Recommendations for oral treatment for adult patients with type 1

PDF] Miglustat for treatment of Niemann-Pick C disease: a

Full article: New therapies in the management of Niemann-Pick type

Treatment outcomes following continuous miglustat therapy in

CNS-accessible Inhibitor of Glucosylceramide Synthase for
Recomendado para você
-
Anesthetic consideration of Niemann-Pick Disease type C21 março 2025
-
PDF] Oxidative Stress: A Pathogenic Mechanism for Niemann-Pick Type C Disease21 março 2025
-
Niemann-Pick-C desease - CERMO-FC21 março 2025
-
Parents of twins with Niemann-Pick find a treatment21 março 2025
-
Niemann Pick Disease - an overview21 março 2025
-
List Niemann-Pick as rare disease, parents of young patients urge21 março 2025
-
Niemann-Pick Disease, Types A and B21 março 2025
-
Niemann–Pick type C disease: cellular pathology and21 março 2025
-
Miglustat for treatment of Niemann-Pick C disease: a randomised21 março 2025
-
White and gray matter alterations in adults with Niemann-Pick21 março 2025
você pode gostar
-
Happy birthday to Smithee A. Herthaka a.k.a. Kaguya's loyal friend, Ai Hayasaka! 💕 [via Kaguya-sama: Love is War?] @aniplexusa21 março 2025
-
Pokemon Black Version and White Version Stickers Gift 2 Pack Bundle : : Toys21 março 2025
-
Casa na Rua Fagundes Varela, 1817, Bacacheri, Curitiba - PR - ID21 março 2025
-
storage.googleapis.com/pai-images/ab3cbaf8440f4da421 março 2025
-
Jill Valentine RE3 Resident evil girl, Jill valentine, Resident evil21 março 2025
-
military gogogo videos full|TikTok Search21 março 2025
-
ICQ Computers21 março 2025
-
Download Anime Summertime Render Episode 23 Sub Indo (FULL EPISODE) Simak Sinopsisnya Disini - Tribunbengkulu.com21 março 2025
-
Jogo de Dama Para Imprimir e Colorir21 março 2025
-
How To Draw Mermaid Hello Kitty, Step by Step, Drawing Guide, by Dawn - DragoArt21 março 2025